Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19Ziad Bakouny, Matthew Puc, Daniel W. Bowles et al.|JAMA Oncology|2022Cited by 63
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19Shuchi Gulati, Yu Shyr, Chih–Yuan Hsu et al.|JAMA Oncology|2023Cited by 10
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort studyGayathri Nagaraj, Gary H. Lyman, Shaveta Vinayak et al.|eLife|2023Cited by 3
Brief Report: Impact of Anti-Cancer Treatments on Outcomes of COVID-19 in Patients With Thoracic Cancers: A CCC19 Registry AnalysisAmit Kulkarni, Narjust Florez, Cassandra Hennessy et al.|Clinical Lung Cancer|2024Cited by 3
Impact of COVID-19 in patients on active melanoma therapy and with history of melanomaDouglas B. Johnson, Matthew D. Tucker, Michael B. Atkins et al.|BMC Cancer|2023Cited by 2